Women fighting an aggressive form of breast cancer may benefit from adding certain drugs to their chemotherapy regimen, and taking them prior to surgery, new research finds. This pre-surgical drug therapy boosts the likelihood that no ...
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
Ledford Medical Electronics has entered into an agreement to expand the sales of Naviscan's organ-specific PET Scanner for use in breast applications in the US. The company said the breast application of the scanner is known as Positron ...
Tags: Ledford Medical, agreement, expand sales, PET Scanner, breast application